Company News

newsicon-company

This section of pediculosis.com is devoted to news about corporate developments and company announcements.

27.08.14 | TyraTech expands retailer base in UK

TyraTech has announced deals with further suppliers in the UK for their VaMousse head lice treatment.

24.07.14 | New Tyratech share & UK distribution deal

Tyratech, inc last week announced a successful share offering along with deals for distribution of its head lice products with UK chemist chains.

05.06.14 | VaMousse now available online across the US

TyraTech Inc recently announced that their VaMOUSSE! range of head lice products are available to purchase online in the United States.

07.10.13 | Tyratech discussing US distribution of head lice products

Tyratech Inc. is in discussions with distributors to increase the exposure of its head lice treatment range to markets in the US.

06.06.13 | Eden Research Licence Agreement

Eden Research has announced an agreement with Neo-Pharma Innovations to develop their terpene-based head lice treatment for commercial sale.

14.12.12 | New funding and efficacy data for Hatchtech

Hatchtech, Pty Ltd have announced the completion of their financing round and published new data on the active ingredient in their DeOvo pediculicide product.

13.12.12 | TyraTech receives Product Registration in UK

TyraTech, Inc, has received notification from the UK regualtory body that their VaMOUSSE!™ head lice product has been registered as a medical device.

27.07.12 | DeOvo granted patent by US PTO

The active ingredient in the DeOvo head lice treatment, produced by Hatchtech Pty Ltd, has been granted a patent by the US Patent and Trademark Office.

09.05.12 | Hatchtech finances Phase III DeOvo trials

The Australian speciality pharma company Hatchtech Pty Ltd has recently announced a new round of funding to support ongoing DeOvo trials, as well as a new CEO.

03.04.12 | New head lice product? Phytalexin and Eden Agreement

An agreement dated 19 March 2012 has been made between Eden Research plc, an agrochemical and encapsulation technology company, and Phytalexin Ltd. This grants Phytalexin exclusive rights to Eden's formulations and encapsulation technologies for use in a head-lice product.

Join us on Twitter

Site Map   |    Privacy Policy   |   Terms & Conditions

© 2012-2013 pediculosis.com — all rights reserved